This morning, we provided an update on clinical development of our
#COVID-19 candidate
#vaccine, including that we've completed enrollment for our pivotal Phase 3 trial in the UK and Phase 2b trial in South Africa. Read our announcement for details.
bit.ly/33vpUDj